FR2849379B1 - Encapsulation d'actifs liposolubles - Google Patents

Encapsulation d'actifs liposolubles

Info

Publication number
FR2849379B1
FR2849379B1 FR0216723A FR0216723A FR2849379B1 FR 2849379 B1 FR2849379 B1 FR 2849379B1 FR 0216723 A FR0216723 A FR 0216723A FR 0216723 A FR0216723 A FR 0216723A FR 2849379 B1 FR2849379 B1 FR 2849379B1
Authority
FR
France
Prior art keywords
liposolubles
encapsulation
active ingredients
ingredients
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0216723A
Other languages
English (en)
Other versions
FR2849379A1 (fr
Inventor
Luc Jugla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COSNESSENS
Original Assignee
COSNESSENS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0216723A priority Critical patent/FR2849379B1/fr
Application filed by COSNESSENS filed Critical COSNESSENS
Priority to CA002513273A priority patent/CA2513273A1/fr
Priority to US10/537,811 priority patent/US20060134222A1/en
Priority to PCT/FR2003/003900 priority patent/WO2004060358A2/fr
Priority to EP03814493A priority patent/EP1578404A2/fr
Priority to JP2004564309A priority patent/JP2006517141A/ja
Priority to AU2003303610A priority patent/AU2003303610B2/en
Priority to CNB2003801077299A priority patent/CN100402019C/zh
Publication of FR2849379A1 publication Critical patent/FR2849379A1/fr
Application granted granted Critical
Publication of FR2849379B1 publication Critical patent/FR2849379B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0216723A 2002-12-26 2002-12-26 Encapsulation d'actifs liposolubles Expired - Fee Related FR2849379B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0216723A FR2849379B1 (fr) 2002-12-26 2002-12-26 Encapsulation d'actifs liposolubles
US10/537,811 US20060134222A1 (en) 2002-12-26 2003-12-24 Process for encapsulating an active lipid-soluble substance by preparing a pit emulsion and emulsion obtained
PCT/FR2003/003900 WO2004060358A2 (fr) 2002-12-26 2003-12-24 Procede d'encapsulation d'un principe actif liposoluble par preparation d'une emulsion pit et emulsion obtenue
EP03814493A EP1578404A2 (fr) 2002-12-26 2003-12-24 Procede d encapsulation d'un principe actif liposoluble par preparation d' une emulsion pit et emulsion obtenue
CA002513273A CA2513273A1 (fr) 2002-12-26 2003-12-24 Procede d'encapsulation d'un principe actif liposoluble par preparation d'une emulsion pit et emulsion obtenue
JP2004564309A JP2006517141A (ja) 2002-12-26 2003-12-24 Ｐｉｔエマルジョンを作成することにより脂溶性活性成分のカプセルを形成する方法及びそのエマルジョン
AU2003303610A AU2003303610B2 (en) 2002-12-26 2003-12-24 Method of encapsulating an active lipid-soluble substance by preparing a PIT emulsion and emulsion obtained
CNB2003801077299A CN100402019C (zh) 2002-12-26 2003-12-24 用制备pit乳液包胶活性脂溶性物质的方法及制得的乳液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216723A FR2849379B1 (fr) 2002-12-26 2002-12-26 Encapsulation d'actifs liposolubles

Publications (2)

Publication Number Publication Date
FR2849379A1 FR2849379A1 (fr) 2004-07-02
FR2849379B1 true FR2849379B1 (fr) 2005-02-11

Family

ID=32480214

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0216723A Expired - Fee Related FR2849379B1 (fr) 2002-12-26 2002-12-26 Encapsulation d'actifs liposolubles

Country Status (8)

Country Link
US (1) US20060134222A1 (fr)
EP (1) EP1578404A2 (fr)
JP (1) JP2006517141A (fr)
CN (1) CN100402019C (fr)
AU (1) AU2003303610B2 (fr)
CA (1) CA2513273A1 (fr)
FR (1) FR2849379B1 (fr)
WO (1) WO2004060358A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4452187B2 (ja) * 2003-05-07 2010-04-21 イーファック・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンディートゲゼルシャフト フレグランスおよびアロマの目標とする放出のための組成
KR20110096132A (ko) * 2008-11-26 2011-08-29 리포프로틴 테크놀로지스, 인코포레이티드 레스베라트롤의 향상된 생활성 제제
BE1020154A5 (nl) 2012-03-22 2013-05-07 Omega Pharma Innovation & Dev Nv Samenstelling voor de behandeling van pediculose en overeenkomstig productiewerkwijze.
KR101645440B1 (ko) * 2014-07-23 2016-08-05 코스맥스 주식회사 다량의 유분을 포함하면서 피부개선효과가 우수한 하이드로겔 마스크의 제조방법 및 이를 통하여 제조된 하이드로겔 조성물
CN109330914B (zh) * 2018-11-28 2022-02-01 广州艾卓生物科技有限公司 一种纳米神经酰胺乳液及其制备工艺和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079322A (en) * 1990-05-30 1992-01-07 The Dow Chemical Company Multifunctional cyclobutarene peroxide polymerization initiators
FR2715843B1 (fr) * 1994-02-09 1996-04-12 Oreal Compositions cosmétiques antisolaires, procédé de préparation et utilisation.
DE19923785A1 (de) * 1999-05-25 2000-11-30 Cognis Deutschland Gmbh Verwendung von PIT-Emulsionen in Fermentationsverfahren
DE19950089A1 (de) * 1999-10-18 2001-04-19 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Makroemulsionen oder O/W-Mikroemulsionen, mit einem Gehalt an einem oder mehreren Filmbildnern, welche aus der Gruppe der Copolymere des Polyvinylpyrrolidons gewählt werden
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament

Also Published As

Publication number Publication date
JP2006517141A (ja) 2006-07-20
WO2004060358A3 (fr) 2005-07-21
CA2513273A1 (fr) 2004-07-22
AU2003303610A1 (en) 2004-07-29
CN1731986A (zh) 2006-02-08
FR2849379A1 (fr) 2004-07-02
AU2003303610B2 (en) 2009-01-08
EP1578404A2 (fr) 2005-09-28
US20060134222A1 (en) 2006-06-22
CN100402019C (zh) 2008-07-16
WO2004060358A2 (fr) 2004-07-22

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DE60325153D1 (de) Gekapselte Riechstoffzusammensetzungen
HK1124485A1 (en) Active bromine containing biocidal compositions and their preparation
DK1276387T3 (da) Indkapsling af fødevareinfredienser
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
NO20034127L (no) Forbedring av aromainneholdende bestanddeler
NO20020185D0 (no) Formuleringer av IL-11
NO20026209D0 (no) Endoparasitticidale midler for frivillig oralt inntak av dyr
NO20044916L (no) Preparater av sulfinylacetamid
ID27728A (id) Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal
DE50213466D1 (de) Fungizide wirkstoffkombinationen
DE60036093D1 (de) Antagonisten des gardos-kanals
AU2003210454A8 (en) Dendritic encapsulation of active agents
ATE433781T1 (de) Haarpflegezusammensetzungen
DE50210292D1 (de) Fungizide desinfektions- und konservierungsmittelzusammensetzungen
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
FR2849379B1 (fr) Encapsulation d'actifs liposolubles
ITRM20010445A0 (it) Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
DE60230292D1 (de) Aktivsauerstoff erzeugendes material
SE0501015L (sv) Befuktning av liten mängdvara
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
ITMI20020624A0 (it) Composizioni ad attivita' biostimolante
FI20020360A0 (fi) Biologisesti aktiivisen tuotteen uusi käyttö
IS6857A (is) Lyfjafræðileg samsetning sem innheldur sítalópram

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090831